Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05864144
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2023-04-21
Brief Title:
A Study of SNS-101 Anti VISTA Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Sponsor:
Sensei Biotherapeutics Inc
Organization:
Sensei Biotherapeutics Inc
Organization Data
Organization:
Sensei Biotherapeutics Inc
Class:
INDUSTRY
Study ID:
SNS-101-2-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sensei Biotherapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Regeneron Pharmaceuticals | INDUSTRY |